09/2020: UGA Biopharma GmbH participates at the virtual CPhI Festival of Pharma 2020

UGA Biopharma GmbH will participate in the virtual CPhI Festival of Pharma 2020 over eleven days in October. The CPhI Festival will take the form of a combination of online webinars and networking platforms.

UGA will use the session to showcase its fast track Cell Line Development service for biologics and biosimilars, accompanied by its proprietary First CHOice® cell culture media and feeds, which can be used to boost the production of for example therapeutic antibodies, bispecific antibodies, fusion proteins, enzymes and hormones.

CEO Dr. Lars Kober and Business Development Manager Dr. Marcel Nowak will be available throughout the festival to explain key differentiations and advantages for high titer production, quality, fast timelines, high biosimilarity, traceability and UGA’s proven track record.

For more information, please click here.

Contact

UGA Biopharma GmbH
Neuendorfstraße 20a
16761 Hennigsdorf
Germany
E-mail:  info@ugabiopharma.com This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: +49(0)3302 / 2024900